Updated: September 10, 2026 | 12-minute read
A dermatologist dims the exam room lights, positions a narrow-band lamp a few inches from a patient's forearm, and sets a timer for under two minutes. That brief, controlled exposure is ultraviolet phototherapy in clinical practice.
Ultraviolet phototherapy is a medical treatment that uses specific, calibrated wavelengths of ultraviolet light — primarily UVB between 280 and 315 nm — to modulate immune activity and cell turnover inside the skin. Unlike broad sunlight exposure, clinical UV phototherapy delivers a measured dose to a defined area, which is what separates therapeutic use from incidental sun damage.
What follows explains how different UV wavelengths reach different skin layers, which conditions the evidence supports, and how to have an informed conversation with a provider before starting treatment — so you can evaluate whether UV phototherapy belongs in your care plan.
Quick answer: UV phototherapy is prescribed medical care, most often NB-UVB around 311–313 nm or PUVA/UVA-based treatment for selected conditions. UVC Ultraviolet Phototherapy is not a standard dermatology treatment; UVC used for disinfection must not be self-applied to skin or eyes.
How ultraviolet phototherapy works at a biological level
Ultraviolet phototherapy cross-section of UV light penetrating skin layers
The therapeutic window for ultraviolet phototherapy is narrow by design — measured in nanometers and millijoules per square centimeter — and that precision is exactly what separates it from ordinary sun exposure.
Ultraviolet phototherapy is a medical treatment that directs specific wavelengths of ultraviolet radiation at skin and tissue cells to trigger controlled biological responses. Dermatologists prescribe it for a range of conditions, most commonly inflammatory and pigmentation disorders. The treatment works not by heating tissue, but by initiating photochemical reactions inside living cells.
The same diagnosis does not automatically mean the same light treatment. The useful wavelength, treatment area, starting dose, frequency, and review schedule depend on the condition, the patient's skin response, medicines, prior UV exposure, and the device used.
UV light sits just below visible light on the electromagnetic spectrum, spanning roughly 100–400 nm. Within that range, the three bands behave very differently. UVA (315–400 nm) penetrates more deeply into the skin than UVB. UVB (280–315 nm) is absorbed primarily in the epidermis, where it affects keratinocytes and immune cells. UV-C (100–280 nm) is almost entirely absorbed by the Earth's atmosphere and by the outermost layers of skin; it is used primarily for disinfection. UVC Ultraviolet Phototherapy is not a standard dermatologic treatment modality and should not be confused with medically supervised UVB, UVA1, or PUVA phototherapy.
The photochemical mechanism differs by wavelength. UVB photons are absorbed by DNA directly, forming pyrimidine dimers that trigger apoptosis in rapidly dividing or overactive immune cells — a key reason it suppresses the inflammatory cycles driving psoriasis and eczema. UVB also converts 7-dehydrocholesterol in the skin into previtamin D3, the starting point for vitamin D synthesis. UVA, used clinically in combination with psoralen (a photosensitizing compound), reaches deeper immune populations and is better suited for conditions requiring dermal penetration.
Therapeutic UV is calibrated: dose, wavelength, and session duration are selected to achieve a clinical effect while reducing avoidable erythema and unnecessary exposure. UV radiation can still cause biological damage, so treatment requires an individualized, clinician-supervised protocol rather than self-directed exposure.
What conditions are treated with UV phototherapy
Dermatologist administering narrowband UVB phototherapy treatment in clinical light booth
A common belief is that UV phototherapy is used mainly for psoriasis. Its established dermatology uses are broader, but suitability and strength of evidence vary substantially by condition and modality.
Psoriasis responds because UVB radiation slows the keratinocyte proliferation that drives plaque formation and suppresses the local T-cell activity fueling inflammation. Vitiligo responds differently — UVB stimulates residual melanocytes in the border zone of depigmented skin, promoting repigmentation over time. Atopic dermatitis (eczema) benefits from UV-induced immune modulation in the epidermis, reducing the Th2-dominant inflammatory state. Mycosis fungoides, an early-stage cutaneous T-cell lymphoma, responds because the malignant T-cells in the skin are directly targeted by UVB-induced apoptosis.
Beyond those headline indications, phototherapy has documented use in prurigo nodularis, chronic pruritus (generalized itch without a clear skin lesion), lichen planus, and certain autoimmune conditions like morphea. These are less often listed on competitor pages but are real clinical uses supported by dermatology guidelines.
Treatment schedules typically run two to three sessions per week. Cumulative dose is tracked in millijoules per square centimeter, with each session escalating gradually from a test dose calibrated to the patient's Fitzpatrick skin phototype. Full-body cabinet systems are standard in dermatology clinics; handheld and targeted devices serve patients with localized plaques or limited access to clinic-based care.
The unit "mJ/cm²" describes radiant exposure: irradiance over time. It is not a universal prescription. A number from another device, clinic, skin type, or diagnosis cannot be safely copied because lamp output, distance, treatment geometry, calibration, and individual sensitivity change the delivered exposure.
Honest outlook: response time varies by condition, body site, skin type, modality, and adherence. Some patients improve within weeks, while vitiligo commonly requires several months before repigmentation is visible. Whether any maintenance treatment is appropriate should be decided by the treating dermatologist; it is not a routine requirement for every patient. Contact your dermatologist promptly if you experience blistering, marked skin reactions, or no response by the planned review point.
Three commonly used UV phototherapy modalities compared
Comparison of broadband UVB, narrowband UVB 311 nm, and PUVA phototherapy treatment setups
Choosing a phototherapy modality is not simply a question of availability — it involves weighing effectiveness, cumulative risk, and how treatment fits into a patient's life. Before asking your provider which is right for you, it helps to understand what the three main options actually do differently.
Broadband UVB emits a wider UVB spectrum and remains an effective option in selected settings. Narrowband UVB, centered around 311–313 nm, is now commonly used because it can be more efficient and less likely to cause phototoxic erythema for several conditions, including psoriasis and vitiligo. PUVA combines oral or topical psoralen (a photosensitizing agent) with UVA exposure. It can be useful for selected conditions, but it has more complex safety requirements and a clearer long-term photocarcinogenic risk than NB-UVB.
Excimer lasers and lamps deliver targeted 308 nm UVB to a precisely defined area. They can suit localized plaques or vitiligo patches where full-body cabinet exposure would irradiate more uninvolved skin.
Before selecting any equipment or entering a phototherapy program, these are the questions worth asking:
- Is the device calibrated and dose-tracked, or is output estimated?
- Does the setup include UV-blocking eye protection as a non-negotiable step?
- What is the total planned course, and how is cumulative dose logged?
- Is a dermatologist reviewing progress at defined intervals rather than at the end of the course?
- If considering home equipment, has the device's actual irradiance output been independently verified?
Home UV phototherapy units can be appropriate for selected patients under physician supervision. A medically appropriate home program requires a device intended for the prescribed use, clear instructions, training, dose records, and scheduled clinical review. Properly managed home UVB can be an effective alternative to office-based treatment for eligible patients.
Do not substitute a consumer UV lamp, tanning device, red-light panel, or disinfection lamp for prescribed phototherapy. These devices differ in spectrum, controls, intended use, and risk profile.
One category worth distinguishing clearly: red and near-infrared light devices use wavelengths outside the UV spectrum and do not provide UV phototherapy. Their mechanisms and clinical evidence differ from UV-based treatments, so they should not be substituted for a prescribed UV phototherapy plan for a specific skin condition.
Risks, benefits, and what the evidence actually shows
UV phototherapy benefits and risks infographic with clinical icons
Narrowband UVB phototherapy produces clinically meaningful clearance or significant improvement in psoriasis for the majority of patients who complete a standard course, according to dermatology clinical guidelines — making it one of the most evidence-backed non-systemic treatments available for moderate-to-severe disease.
That result matters because the alternatives at this severity level — systemic immunosuppressants or biologic therapies — carry their own risk profiles and cost burdens. A course of controlled phototherapy, by comparison, delivers its effect locally in the skin with minimal systemic exposure.
The documented benefits are real. Symptom reduction in psoriasis and vitiligo is supported by decades of clinical use. Patients in phototherapy programs frequently report reduced reliance on topical corticosteroids, which matters because long-term steroid use carries its own skin-thinning and systemic risks. Quality-of-life improvements in chronic inflammatory skin disease are measurable and sustained during active treatment.
The risks deserve equally direct treatment. PUVA has an established long-term risk of photoageing and skin cancer. For NB-UVB, long-term cancer-risk evidence is less certain and should be interpreted in light of cumulative exposure and individual risk factors. Short-term side effects include erythema (sunburn-like redness), occasional blistering if dose escalation is too aggressive, and potential hyperpigmentation. Eye protection must follow the device instructions and the treating clinic's protocol because unprotected UV exposure can injure the eye.
The benefit-risk calculation lands favorably for most patients with moderate-to-severe chronic skin disease that hasn't responded to topical treatments, provided exposure is logged and total lifetime dose is actively monitored. The word "monitored" is doing real work in that sentence — phototherapy without a running record of cumulative dose is meaningfully riskier than phototherapy with one.
How to know if UV phototherapy is right for you — and what to ask your provider
Patient and dermatologist reviewing UV phototherapy treatment plan at clinic
Not every patient with a qualifying diagnosis is automatically a good candidate for UV phototherapy. Dermatologists evaluate several factors before recommending a course, and knowing what those are helps you enter the conversation as an informed participant.
Candidacy assessment includes skin phototype, the diagnosis and extent of disease, prior UV exposure, photosensitizing medicines, eye history, and personal skin-cancer risk. Starting dose may be based on minimal erythema dose testing, skin phototype, or a local protocol; it is not determined by one universal method. A personal history of skin cancer, photosensitivity disorders, and certain medications require individualized specialist assessment. Phototherapy may be considered at different points in care depending on the condition and severity; it is not universally reserved only after topical treatment has failed.
A realistic course uses a written clinician-directed schedule with cautious dose adjustment based on skin response. A review point is set according to the diagnosis and protocol. Treatment may stop after a planned course, adequate response, lack of response, or an adverse reaction; there is no universal maximum cumulative dose or one timetable for every patient.
Cost varies significantly by country, healthcare system, and setting. Clinic-based sessions may be covered by insurance when the diagnosis meets criteria, but coverage rules differ by country and payer. Home device investment is a one-time cost with different tradeoffs in clinical oversight and output reliability.
Before your appointment, bring these questions:
- How many total sessions are planned, and how will cumulative dose be recorded?
- Which modality is recommended for my specific diagnosis and skin type, and why?
- What symptoms should make me call before my next scheduled session?
- How will we define success at the mid-course review?
- Are there medications I currently take that need to be adjusted or timed around sessions?
A provider who answers these with specifics — not generalities — is the one whose treatment plan is worth following.
Key takeaways
Ultraviolet phototherapy is a controlled clinical treatment that delivers specific UV wavelengths — most commonly narrowband UVB at 311–313 nm — directly to skin tissue to suppress the overactive immune responses behind conditions such as psoriasis, eczema, and vitiligo. Dose is measured precisely in millijoules per square centimeter, and that precision is what makes it therapeutic rather than damaging. Unlike casual sun exposure, every session is calibrated to a treatment protocol, which means outcomes depend heavily on consistency and clinical supervision.
FAQ
How much does UV phototherapy cost?
UV phototherapy cost varies widely by country, clinical setting, device type, and insurance coverage. Ask the clinic and your insurer for a written estimate before starting. Home phototherapy may involve a higher upfront device cost but can reduce travel and visit burden for selected patients.
What are the risks of UV light therapy?
The primary risks are short-term skin reactions — redness, itching, and burning similar to sunburn — and, with long-term use, skin ageing and potential skin-cancer risk, particularly with PUVA (psoralen plus UVA) treatment. NB-UVB generally has a more favorable risk profile than PUVA, but its long-term cancer risk should not be described as zero. Eye protection is required when specified by the device instructions and clinical protocol because unprotected UV exposure can cause acute eye injury and may contribute to cataract risk.
How long does UV light therapy take to work?
Most patients see measurable improvement after 15 to 20 sessions, which at a typical schedule of two to three sessions per week means noticeable change in roughly six to ten weeks. Some conditions, particularly vitiligo, respond more slowly and may require three to six months of consistent treatment before repigmentation becomes visible. Response speed depends on the condition being treated, the starting dose, and how well the individual's skin tolerates dose escalation.
Do not increase exposure time to speed up results. A missed session, redness, blistering, a medication change, or a new photosensitivity symptom should be discussed with the treating clinic before the next exposure.
What are the potential downsides of using phototherapy?
The practical downsides go beyond side effects: the treatment schedule can require multiple clinic visits per week for months, creating travel, time, and cost burdens. People with a personal history of skin cancer or other important photosensitivity risk factors need individualized specialist assessment before treatment. Home units can reduce scheduling burden, but proper training and a physician-managed protocol remain essential.
References
- World Health Organization. "Ultraviolet radiation." https://www.who.int/health-topics/ultraviolet-radiation
- U.S. Food and Drug Administration. "Ultraviolet (UV) Radiation." https://www.fda.gov/radiation-emitting-products/tanning/ultraviolet-uv-radiation
- British Association of Dermatologists. "Phototherapy – NB-UVB." https://www.bad.org.uk/pils/phototherapy-nb-uvb
- American Academy of Dermatology. "Psoriasis treatment: Phototherapy." https://www.aad.org/public/diseases/psoriasis/treatment/medications/phototherapy
- Gelfand JM, et al. Home- vs Office-Based Narrowband UV-B Phototherapy for Psoriasis: a randomized clinical trial. JAMA Dermatology, 2024. https://pubmed.ncbi.nlm.nih.gov/39319513/
Related Guides
Related guides on ultraviolet phototherapy and light therapy modalities
UV is only a small component of solar radiation, but its effects on skin are biologically significant. This is why medically supervised UV-based phototherapy remains important in dermatology while non-UV light technologies should be evaluated separately for their own evidence and intended uses.
Understanding what ultraviolet phototherapy is becomes clearer when you can see how its individual components — UVA, UVB, and UV-C — behave differently in tissue, and how those differences translate into distinct clinical choices. The guides below break down each major aspect in more depth, from the electromagnetic basics to real-world treatment protocols and the growing landscape of photobiomodulation.
The articles linked here explore each major dimension of ultraviolet phototherapy and related light therapy modalities.
- What is the difference between UVA, UVB, and UV-C? — A direct comparison of penetration depth, cellular targets, and clinical relevance across all three UV bands, with notes on why UV-C light used for disinfection stays strictly out of therapeutic protocols.
- How does narrowband UVB therapy work? — Covers the photochemical mechanisms behind psoriasis, vitiligo, and eczema treatment, including dose calculation and common treatment schedules.
- Red and near-infrared light therapy explained — Examines how 660 nm and 850 nm wavelengths interact with mitochondrial chromophores, distinct from UV mechanisms but increasingly used alongside dermatological care in recovery and skin wellness settings.
- Home versus clinical phototherapy: what changes? — Looks at how device class, irradiance levels, and treatment distance affect both safety and outcomes when moving treatment out of a clinic.
- Light therapy certifications and compliance guide — Explains what FDA registration, CE marking, and ISO 13485 actually mean for buyers evaluating devices, and which documents to request before purchasing.
Each guide stands on its own, so start with whichever question is most pressing for your situation.